Development of purified antibodies that kill virus infected cells. This proposal will develop panels of purified and monoclonal antibodies that kill virus infected cells. These antibodies may show efficacy in preventing HIV infection. This is new technology that could subsequently be harnessed to protect or limit the devastating effects of chronic viruses such as HIV.
Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situation ....Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situations, or to be used as a public health tool in situtions to control outbreaks in those most susceptible to serious disease. The production system that enabled the creation of the technology is the advanced Australian dairy industry. Farmers with herds participating will receive a significant income benefit from, what was before, largely a waste product.Read moreRead less
Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spr ....Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spread. This project will identify key receptor interactions and map the extent of invasion. By advancing our basic understanding of these important viruses and their uptake at an abundantly exposed but little explored anatomical site, the project can establish a basis for vaccinating against chronic disease.Read moreRead less